1 μM) and concentration–response curves were performed for NP isolated by C. o. abyssus, Coa_NP2 (10−11 to 10−7M), in both e+ and e− aortic rings. In another set of experiments, concentration–response curves for Coa_NP2 (10−11 to 10−7M) were compared with phenylephrine check details precontracted endothelium-intact tissues in the absence or presence of ISATIN (1 μM, a potent guanylate cyclase-coupled atrial natriuretic peptide receptor type A antagonist) [13] and [25] and incubated for 30 min. In the last set of experiments, concentration–response curves for Coa_NP2 (10−11 to 10−7M) were performed
on aortic rings precontracted with isosmotic high-potassium (K+ 80 mM) Krebs–Henseleit solution [10] and [12]. After the infusion of Coa_NP2 extracted from C. o. abyssus and the blood pressure assessment, levels of plasma nitrite were measured by colorimetric Griess methods. In these assays, 50 μl of the samples SB431542 datasheet were incubated with the same volume of Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride in 5% phosphoric
acid). Nitrite levels were determined by comparison with a standard curve obtained by incubating sodium nitrate (10–200 μM) with reductase, buffered and measured at 550 nm in a multiwell plate reader (HIDEX, Shimadzu, Japan). The results were reported as micromolar concentrations (μM) of NO2 [26]. After the infusion of Coa_NP2 Atazanavir extracted from C. o. abyssus and the blood pressure assessment, levels of plasma nitrite were analyzed in duplicate for their nitrite content using an ozone-based reductive chemiluminescence assay as previously described [27]. Briefly, to measure nitrite concentrations in plasma, 100 μl of plasma samples were injected into a solution of acidified tri-iodide, purging with nitrogen in-line with a gas-phase chemiluminescence NO analyzer (Sievers Model 280 NO analyzer, Boulder, CO). Approximately 8 ml of tri-iodide solution (2 g potassium iodide
and 1.3 g iodine dissolved in 40 ml water with 140 ml acetic acid) was placed in the purge vessel, into which plasma samples were injected. The tri-iodide solution reduces nitrites to NO gas, which is detected by the NO analyzer. After the release of the primary sequence of Coa_NP2, a set of homology modeling studies was carried out in order to obtain tertiary structure information following a previously described protocol [14]. Initially, a template search was performed by SWISS-MODEL workspace, which identified several close homologue-resolved structures by SWISS-MODEL Template Library (SMTL). As the alignment between the target and the templates sequences showed high similarity, the automated mode was chosen to build the tridimensional structure target. The models were then refined with the AMBER 9.0 package. The models built were prepared using Leap and submitted to Sander software for geometry refinement.